GLG Life Tech Corporation
GLGLF
$0.00
$0.000.00%
| Weiss Ratings | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | C- | |||
| Rating Factors | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.29 | |||
| Price History | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -99.99% | |||
| 90-Day Total Return | -99.99% | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -99.99% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -100.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.12 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Dec 31, 2024 | |||
| 52-Week High Price (Date) | Jul 22, 2024 | |||
| Valuation | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 38.00 | |||
| Enterprise Value | 60.48M | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | 1.72 | |||
| Earnings Per Share Growth | -422.34% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 5.55 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | 31.86 | |||
| Enterprise Value/EBIT | 33.78 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 38.39M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604 285 2602 | |||
| Address | 13071 Vanier Place Richmond, BC V6V 2J1 | |||
| Website | www.glglifetech.com | |||
| Country | Canada | |||
| Year Founded | 1998 | |||
| Profitability | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 16.42% | |||
| Profit Margin | 606.36% | |||
| Management Effectiveness | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.32% | |||
| Return on Equity | -- | |||
| Income Statement | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 10.90M | |||
| Total Revenue (TTM) | 10.90M | |||
| Revenue Per Share | $0.28 | |||
| Gross Profit (TTM) | 3.62M | |||
| EBITDA (TTM) | 1.90M | |||
| EBIT (TTM) | 1.79M | |||
| Net Income (TTM) | 66.10M | |||
| Net Income Avl. to Common (TTM) | 66.10M | |||
| Total Revenue Growth (Q YOY) | 40.00% | |||
| Earnings Growth (Q YOY) | 17.06% | |||
| EPS Diluted (TTM) | 1.72 | |||
| EPS Diluted Growth (Q YOY) | 1,395.35% | |||
| Balance Sheet | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 191.30K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 14.74M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -72.53M | |||
| Current Ratio (Q) | 0.170 | |||
| Book Value Per Share (Q) | -$1.89 | |||
| Total Assets (Q) | 15.12M | |||
| Total Current Liabilities (Q) | 86.96M | |||
| Total Debt (Q) | 60.61M | |||
| Total Liabilities (Q) | 87.65M | |||
| Total Common Equity (Q) | -72.60M | |||
| Cash Flow | GLGLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -7.10K | |||
| Cash from Financing (TTM) | -738.80K | |||
| Net Change in Cash (TTM) | -50.60K | |||
| Levered Free Cash Flow (TTM) | -58.44M | |||
| Cash from Operations (TTM) | 2.78M | |||
